None of the three compounds have safety data in this context
GHK-Cus advantage is that it addresses collagen production alongside 4,000+ other genes, providing comprehensive tissue support rather than isolated collagen induction
Any company that aspires to prove the safety and effectiveness of a peptide will turn away from them, knowing that compounders will simply be able to sell them without ever needing to generate safety and effectiveness evidence. Indeed, Lurie continued, financial analysts are predicting a $2.2 billion telehealth marketing opportunity if these seven peptides are approved for compounding
NT: Writingoriginal draft, Writingreview and editing, Software, Visualization
PubMed (2024) CagrilintideSemaglutide in adults with overweight/obesity and type 2 diabetes ScienceDirect (2024) Efficacy and safety of CagriSema 2.4 mg + 2.4 mg in type 2 diabetes PMC (2019) Subcutaneous drug injection: pharmacologic review Pure Lab Peptides Cagrilintide + Semaglutide (10 mg Blend) product page Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides